These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1480022)

  • 1. Plasminogen activator expression and matrix degradation.
    Rifkin DB
    Matrix Suppl; 1992; 1():20-2. PubMed ID: 1480022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
    Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
    Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional regulation of gene expression in the plasminogen activation system.
    Montuori N; Rossi G; Ragno P
    Biol Chem; 2002 Jan; 383(1):47-53. PubMed ID: 11928821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
    Niedbala MJ; Sartorelli AC
    Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasmin system in airway remodeling.
    Kucharewicz I; Kowal K; Buczko W; Bodzenta-Łukaszyk A
    Thromb Res; 2003; 112(1-2):1-7. PubMed ID: 15013265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericellular enzymatic hydrolysis: implications for the regulation of cell proliferation in the vessel wall and the bone marrow.
    Brunner G; Preissner KT
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):625-39. PubMed ID: 7841321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of black-pigmented bacteria on the plasminogen-plasmin system in human pulp and osteoblastic cells.
    Yang SF; Hsieh YS; Huang FM; Yang LC; Chang YC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):621-5. PubMed ID: 12738955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasminogen activator inhibitor system in bone cell function.
    Allan EH; Martin TJ
    Clin Orthop Relat Res; 1995 Apr; (313):54-63. PubMed ID: 7641498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 and diabetic nephropathy.
    Lee HB; Ha H
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage.
    Martel-Pelletier J; Faure MP; McCollum R; Mineau F; Cloutier JM; Pelletier JP
    J Rheumatol; 1991 Dec; 18(12):1863-71. PubMed ID: 1724464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.